We've got some time before Monday's opening bell, so let's ease into it.


Sunday Night Reminder: Flora Growth Corp. (FLGC) Is A Former Breakout Champ And Company On The Rise

August 29th

Good Evening,

We've got some time before Monday's opening bell, so let's ease into it.

I've been tracking a past champ closely and think it could be on the verge of making a major statement in the markets.

After undertaking some recent, game-changing corporate actions, this company could soon be at the forefront of the "Green Leaf" revolution.

The Best Part?

We know how explosive this profile can be from past experience.

Brought to your attention back for the morning of May 24th, this profile opened up that session at $3.58.

All it did from there was rocket approximately $17.00+ to a high of $21.45 on August 16th.

That vertical eruption resulted in this profile surging approximately 499% in just a few short months.

See what I mean? Explosive.

Now with it trading at around half of its recent 52-week high from the middle of this month, it may be hanging around undervalued levels at this very moment.

For Monday, August 30th, there is only one Nasdaq profile to have at the top of your radar:

*Flora Growth Corp. (NASDAQ: FLGC)*

Flora Growth Corp. (NASDAQ: FLGC) has recognized this Colombian opportunity and to put it quite simply, has pounced to create a low-cost cultivation operation that could provide them with a global footprint in the years to come.

Flora is a cann-a-bis company that will leverage natural, cost-effective cultivation practices to supply cann-a-bis derivatives to its diverse business divisions of cosmetics, he-mp textiles, and food and beverage.

As the operator of one of the largest outdoor cultivation facilities, Flora strives to market a higher-quality premium product at below market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, Flora creates premium products that help consumers restore and thrive.


New Colombian Regulation Further Increases Revenue Potential

The President of Colombia has accepted and signed into effect some exciting revisions related to the existing Colombian cann-a-bis laws which allow for the:

  • Sale and export of raw cann-a-bis materials, namely dried flower, to international markets
  • Manufacturing, sale, and export of ingestible cann-a-binoid products in Colombia
  • Promotion and advertising of cann-a-bis brands and products in Colombia

These new regulations are expected to allow Flora to increase near-term and long-term revenue, optimize its product supply chain both domestically and abroad.(6)


New $11.50 Price Target From MKM Partners

Highlights from the report:

1H21 Recap: Flora reported 1H21 revenue of $2mn with a 60% gross margin, generating a net loss of -$4mn (-$1mn adjusted for one-time expenses). Flora guided to 2H21 revenue of $9mn-$11mn exclusive of announced M&A (Heimat and Vessel with combined trailing 12 mo revenue of $14mn) and exclusive of dried flower shipments.

This organic guidance is a sharp acceleration led by Kasa Wholefoods/Tropi and Flora Lab/Flora Beauty. Importantly, these organic numbers ($9mn-$11mn) were above our initial estimates ($7.6mn in 2H). When we launched on Flora, our numbers did not include any changes to Colombian legislation, nor did they include contributions from M&A.

The deals, which could close shortly, and shipments of dried CB flower provide further upside to guidance (and our former numbers), setting the stage for run-rate annual revenue of >$40mn as Flora exits 2021. Importantly, it will take very little revenue growth for Flora to become profitable. At a 60% gross margin, Flora would need to generate just another $2mn in organic revenue to become profitable (assuming organic revenue doesn't carry much additional SG&A).

We are raising our 2H21 and FY22 estimates for better than expected organic growth (2H21 and FY22) and legislative changes (FY22 forward). We are now modeling $12mn (from $7.6mn) in 2H21 net sales and +$1.8mn in adjusted EBITDA (from $0.7mn).

With the higher estimates (incl. legislative changes) our price target is now $11.50 (from $6).

Find the full report here.


Flora Growth Reports H1 2021 Financial Results and Provides Guidance for H2 Revenue Anticipated Between $9-11M USD

H1 2021 Financial Summary:

  • Flora Growth generated revenues of +$2M with a gross profit of 60% (unaudited), as compared to revenues of ~$100K for 2020.
  • Their operating expenses for the first half were $6M, yielding a net loss of $4M (unaudited). However, these results were heavily affected by almost $3M of one-time IPO related expenses (unaudited).
  • At June 30, 2021, Flora’s cash balance was approximately $19M with minimal debt (unaudited).

- Subsequent to June 30th, they have been seeing a substantial cash inflow from the exercise of the warrants sold as part of the Regulation A. To date, they have received commitments of more than $10M (some unfunded), with $7.2M in cash received and an additional $1M pending clearing. They expect to see this amount continue to grow over the following weeks.

  • Flora Growth is a foreign private issuer and is required to submit financial results on a half-year basis, with a 6-month window to file the unaudited results. Flora anticipates filing its full results with the SEC in the following weeks.

Q2 2021 Operational Highlights:

  • Completed an IPO and successful public listing on the Nasdaq Capital Market exchange under the ticker symbol "FLGC"; Flora is the first known all-outdoor grower ever listed on the NASDAQ, the first cann-a-bis company to list via a traditional IPO on an American exchange, and has what management believes the largest licensed cultivation footprint in Colombia
  • Announced intent to acquire 100 percent of Koch & Gsell, manufacturer of the leading Swiss he-mp and tobacco pre-roll brand Heimat
  • Executed a strategic in-vest-ment of $2.4M into Hoshi International, opening up distribution of Flora’s product portfolio into the European Union ("EU")
  • Expanded into U.K. and Central American markets with sales to new international distribution partners; bringing the total countries that Flora and its divisions currently have product in market to 13
  • Bolstered board of directors and management team with key additions:

- Marc Mastronardi – Director

- Jason Warnock – Chief Revenue Officer

- Lee Leiderman – Chief Financial Officer

  • Formed Science Advisory Team and began expansion of scientific and academic endeavors with key addition:

- Appointed Dr. Annabelle Manalo-Morgan, PhD, as Lead Scientific Advisor

  • Made a commitment to environmental sustainability across the Flora value chain, including throughout cultivation and manufacturing practices, as well as screening all potential input materials, packaging, and social outcomes associated with each product in the portfolio
  • Formed Flora Lab manufacturing division that operates a modern 16,000-square-ft manufacturing facility and holds multiple GMP certifications with a diversified portfolio including over 190 products and 63 over-the-counter ("OTC") products registered and licensed with INVIMA (FDA-equivalent in Colombia).

Operational Highlights Subsequent to Period End:

  • Kasa Wholefoods., Flora’s food & beverage division, signed a sales agreement to supply food products to Colombia’s largest consumer packaged goods ("CPG") distributor, Tropi, which has 130,000+ distribution points across 38 cities in Colombia; Kasa has since completed its first purchase order valued at approximately $1.1M and expects this initial agreement to generate additional revenue of its CB and he-mp portfolio, expecting future sales to reach approximately $2M per month
  • Announced intent to acquire 100 percent of Vessel Brand, an industry leader in luxury cann-a-bis consumer technology
  • Announced intent to form a joint venture with Canadian based Avaria, the manufacturer and owner of KaLaya – an award-winning pain cream distributed nation-wide across Canada
  • As a result of the reformed Colombian cann-a-bis legislation aimed at improving access to cann-a-bis products for Colombians and positioning Colombia as the leader to supply the global cann-a-bis market, Flora immediately announced that it had executed a Letter of Intent with Kiricann, an international distributor with operations in South Africa and distribution agreements in Germany and the EU, to provide its dried flower and derivatives; additionally, the Company announced plans for the manufacturing, sale, and distribution of CB-infused food and beverage products; further plans to increase awareness across its premium brand and product portfolio as a result of the loosened marketing restrictions; and, lastly plans to manufacture custom cann-a-bis pharmaceutical products for the Colombian medical cann-a-bis market
  • Announced intent with Evergreen Pharmacare, a licensed Australian importer and distributor of medical cann-a-bis products, to supply its premium dried flower and derivative products to the Australian medical cann-a-bis and OTC CB markets
  • Flora Beauty division formally launched Ô ("Awe"), its premium brand and product line designed and marketed by founding partner, trend-setter, and global beauty influencer Paulina Vega

Read the full article here.


Colombia: A Potential Game-changer In The Global Cann-a-bis Industry (And How Flora Growth Corp. Could Benefit Greatly)

Long known for its illicit drug trade, Colombia is also a hotbed for agricultural businesses which include everything from coffee to bananas and cut flowers.

These commodities have made Colombia a force in the global market and cann-a-bis could be the next big economic breakout for this developing country.

Roughly 5 years ago, the Colombian government signed the 1787 bill into law. Law 1787 was created to regulate the use of medicinal cann-a-bis and its trade in the country.(4)

By doing this, Colombia joined a slew of other countries looking to explore the potential advantages of using cann-a-bis as an alternative to pharmaceuticals.

Legislators soon saw to create a legal framework allowing for cultivation, extraction, product manufacturing, and exporting of cann-a-bis-related products.

This is where Flora Growth Corp. (NASDAQ: FLGC) comes into play.

"Given its cost advantages, we believe Colombia is positioned to become a major global export hub for cann-a-bis, particularly if producers pursue EU GMP-compliant operating practices." - Canaccord Genuity(1)

The Cosechemos cultivation farm, Flora’s core division, is located in Bucaramanga, Colombia, and is licensed to cultivate 247 acres (100 hectares) of cann-a-bis.

With Cosechemos' demonstrated low production costs, Flora is ready to sell high-quality cann-a-bis at competitive prices.


Cosechemos has launched three successful pilot crop plantings consisting of 4.94 acres with impressive results(1):

  • 30 varieties of non-psychoactive cann-a-bis tested. Demonstrated production cost of $0.06/gram.
  • Optimized cultivation strategy, yielding over 125 grams/plant.
  • Initiated third-party organic and GACP certification in Ql 2020.
  • Cosechemos' extraction facility is currently under construction, with completion expected in Q3 2021. It will be built to EU-GM P standards, and immediately seek EU-GMP certification, Cosechemos plans to cultivate 49 acres in 2021; 9 acres for CB and 40 acres for T-H-C.
  • Additionally, Cosechemos holds rights to an additional 5,268 acres licensed in Puerto Boyaca, Santander, to increase the scale of its cultivation as required.(1)

Low-Cost Colombian Cultivation: Flora’s Cost Advantage(1)


Source: Each company's filings and presentations (FY 2019)

Favorable Growing Conditions

  • 12.8 hours of daily sunlight, 365 days/year
  • Consistent 3 mph wind, decreases incidence of plant-harming pathogens
  • Organic nutrient-rich soil allows for high density planting

Low-Cost Infrastructure

  • Long-term monthly lease of only US$10/acre, with purchase option
  • Six natural spring water deposits on site: water cost $0
  • Low utility costs at less then US$150/month

Locally-Adapted Strategy

  • 3+ years of evaluating strains to perfect growing economics
  • Developing unique organic agronomic management system tailored to Cosechemos' climate and conditions
  • Optimized cultivation strategy to obtain 3+ harvests per year (1.5-3X more than peers), high productivity per area and a high-quality product.

North America vs. Colombia Cann-a-bis Growth Comparisons(1)

North American Cann-a-bis

  • Avg. cost $1.89/gram (source 5) & 20 °F / 6.4-hours of daylight
  • Most grown indoor using artificial light with substantial energy costs and waste
  • Significant costs only to try and reproduce ideal outdoor growing environment of Colombia

Colombian Cann-a-bis

  • Avg. cost $0.06/gram & 65 °F / 12.8-hours of daylight
  • Free natural sunlight and water, nutrient-rich soil
  • High-quality outdoor-grown product

With a +25X cost advantage over its North American counterparts, don’t you think it might be a good time to start paying close attention to Flora Growth Corp. (NASDAQ: FLGC)?

FLGC: More Than A Cann-a-bis Cultivator

While cann-a-bis legalization continues globally, Flora Growth is creating initial demand for its cann-a-bis products through internal brands that capitalize on consumer and competitive industry trends.

Flora expects to be well-positioned with robust infrastructure, reliable supply-chains, and global distribution as the cann-a-bis market is expected to expand rapidly over the next decade.

- Cosechemos: Contracted cultivation facility with 247 acres in Bucaramanga, Colombia; has achieved production costs of US$0.06 per gram.

- Flora Lab: modern manufacturing facility with GMP certifications to supply Flora's medical and consumer brands.

- Flora Beauty: Internally developed portfolio of beauty & skincare products. Founded by former Miss Universe and global beauty influencer Paulina Vega.

- Kasa Wholefood: Portfolio of natural food & beverage products, responsibly sourced from exotic Amazonian fruits.

- He-mp Textiles & Co: Sells textiles made from he-mp to businesses and consumers, starting with inaugural brand Stardog Loungewear.


Flora Growth Corp. (NASDAQ: FLGC) Has An Exceptional Leadership Team

Luis Merchan, President & CEO

Luis Merchan is a proven executive with over a decade of experience in enterprise sales management, corporate strategy, merchandising and expense management, and customer experience. He previously served as Macy’s Inc.’s Vice President of Workforce Strategy and Operations where he managed the enterprise's multi-Bn-dollar P&L expense line for the 540 store portfolio. Throughout his tenure at Macy’s, Mr. Merchan led various sales and marketing initiatives including the B2B corporate sales team that was responsible for $160Mn in annual revenue. Prior to his most recent role, Mr. Merchan held various executive-level roles at Macy’s Inc., including VP of Customer Experience and Selling Support Services and Group VP of National Merchandising and Sales - Beauty, as well as managerial roles at Target Corporation. Mr. Merchan obtained his Bachelor of Industrial Engineering from Pontifical Xaverian University in Bogota, Colombia and his MBA from McNeese State University. He also holds a Graduate Certificate in Marketing Management from Harvard.

Bernie Wilson, Chairman

Dr. Wilson is a senior financial professional. He is the former Vice-Chairman of Price-WaterhouseCoopers LLP and is the Chairman of the Founders Board of the Institute of Corporate Directors. Mr. Wilson has served as Chairman of the Canadian Chamber of Commerce; Chairman of the International Chamber of Commerce - Canada; and Member of the Canada/US Trade Committee. Drawing on his experience as Chairman of the Founders Board of Institute of Corporate Directors, as Lead Director, Mr. Wilson will work with the Board of Directors of Flora and its various standing committees to ensure effective corporate governance practices and to enhance and protect the independence of the board.

Juan Manuel Galan, Strategic Advisor

Juan Galán currently serves as a senior consultant to The World Bank. He is a Colombian politician and former senator of Colombia, serving three terms from 2006 to 2018 as a member of the Colombian Liberal Party. He is also a former professor at the University of Rosario and holds more than 20 years of journalistic, academic, governmental and parliamentary experience. During his time as a senator, Mr. Galán has been a key leader, with 29 bills and 27 debates on political control, and 17 laws to his name. The most relevant of those laws was authoring the medical cann-a-bis law that resulted in the legalization of medical cann-a-bis in Colombia.

Dr. Annabelle Manalo-Morgan, PhD - Lead Scientific Advisor and Forms Science Advisory Team

Dr. Annabelle is a scientist, educator, author, mother of five, and a respected key opinion leader. She is a cell and developmental biologist from Vanderbilt University in Nashville, Tennessee, with a background in neuroscience from Georgetown University. She earned her PhD in Cell and Developmental Biology with a focus in Cardio-Oncology and has since become a philanthropist and entrepreneur focused on pharmaceutical innovation and clinical trial research in medical cann-a-bis.

Javier Franco, VP Agriculture

Javier Franco is a master horticulturist with more than 25 years of experience in the design, implementation and management of cultivation and propagation facilities of more than 30 species of cut flowers in Latin America, mainly in Colombia and Ecuador. Mr. Franco completed his agricultural studies at Zamorano University in Honduras and later at an International Exchange Program at Ohio State University. Mr. Franco has directed technical, commercial and research groups in the cut flower, fruit and vegetable markets in Latin America and has participated in the commercial development of new technologies applied in agribusiness. He has also led the agri-management of organic crops and certifications of Good Agricultural Practices.

10 Reasons To Get Flora Growth Corp. (NASDAQ: FLGC) On Your Radar Now

  1. The company recently listed on the NASDAQ which will provide it with a broader audience and more visibility.(2)
  2. With cann-a-bis' potential upside, Flora Growth Corp. (NASDAQ: FLGC) stock could be surprisingly undervalued.
  3. With possible cann-a-bis legalization on the horizon in the United States, a potential $40Bn TAM cann-a-bis supply/demand gap could be created.(1)
  4. Colombia is poised to become a global low-cost leader in cann-a-bis production(1). Flora Growth’s core division is Cosechemos, a cann-a-bis cultivation and extraction facility located in Bucaramanga, Colombia.
  5. Cosechemos' 10.8 million square feet (247 acres) of licensed cultivation area can make Flora Growth a substantial cultivator in the cann-a-bis industry.(1)
  6. Cosechemos holds rights to an additional 5,268 acres licensed in Puerto Boyaca, Santander, to increase the scale of its cultivation as required.(1)
  7. Flora recently announced it has expanded into the United Kingdom (the “UK”) and Costa Rica, fulfilling initial orders from two new distributors.(3)
  8. Flora’s premium portfolio includes 5 divisions, with 280+ products, and over 70+ medical/cosmetic/other licenses.(1)
  9. The company has a healthy balance sheet including minimal debt and recently completed a $30Mn USD Pre-IPO Equity Financing.(1)
  10. Flora has an accomplished management team; combined, they have raised over $3Bn in public financings and listed in excess of 50 public companies.(1)


Drop what you’re doing this second and pull up Flora Growth Corp. (NASDAQ: FLGC) before it’s too late. Also, when you have a second, do this:


Before Monday's opening bell, get FLGC on your radar.


Kai Parker


Source 1
Source 2
Source 3
Source 4
Source 5: 2019 Average of Aphria, Tilray, Sundial, Aurora
Source 6

(Always Remember The Stock Prices Could Be Significantly Lower Now From The Dates I Provided.)

Disclosure: I am not a lice.nsed finan.cial adviser. All potential percentage gains are based on from the low to the high of day. StockWireNews full disclosure is to be read and fully understood before using StockWireNews website, or joining StockWireNews' email or text list. By viewing StockWireNews website and/or reading Stock Wire News email or text newsletter you are agreeing to StockWireNews full disclosure which can be read at www.stockwirenews.net/disclosure Make sure to always do your own research and due diligence on any day and swing profile I bring to your attention. StockWireNews (stockwirenews . com) is owned by StockNewsWire LLC, a limited liability company. An owner of StockNewsWire, LLC owns an interest in the limited liability company that owns and operates small cap firm . com (“SCF”), an interest in the limited liability company that owns and operates fierceinvestor . com (“FI”), an interest in the limited liability company that owns and operates stockstreetwire . com (SSW), and an interest in the limited liability company that owns and operates nasdaq wire news . com (NWN) . From time to time, StockWireNews, SCF, FI, SSW, and/or NWN will publicly disseminate information about a company via website, email, SMS and other points of media. Pursuant to an agreement between StockNewsWire, LLC, and Flora Growth Corp., StockWireNews was hired for a period beginning on 5/22/21 and ending on 5/24/21 to publicly disseminate information about (FLGC) via Website, Email and SMS. We were paid thirty thousand USD via bank wire transfer. We own zero shares of (FLGC). Pursuant to an agreement between StockNewsWire, LLC, and Flora Growth Corp., StockWireNews was hired for a period beginning on 8/28/21 and ending on 8/30/21 to publicly disseminate information about (FLGC) via Website, Email and SMS. We were paid thirty thousand USD via bank wire transfer. We own zero shares of (FLGC). To date we have now been compensated a total of sixty thousand USD via bank wire transfer to disseminate information about (FLGC).